Alfred Bonati, the founder of the Bonati Spine Institute in Florida, those taking GLP-1s should cease taking the drugs weeks before surgery, just to be safe
That does not mean your whole week has to revolve around the injection
JCI 8th Edition (PCI.7 & COP.5): Require evidence-based SSI prevention patient risk assessment including BMI, glucose control, and comorbidities as core elements
Smaller droplets also change the LI as they move over the sensor apertures
During this stage, your medical history and weight loss goals are evaluated virtually, ensuring a personalized tirzepatide treatment plan tailored to your needs
Lip 2 , Ching Hui Sia 1 , Benjamin Tan 1 1 National University of Singapore, Singapore, Singapore, 2 University of Liverpool, Liverpool, United Kingdom Background and Aims: The differential impact of atrial fibrillation detected after stroke (AFDAS) compared to known atrial fibrillation (kAF) on outcomes following thrombolysis with intravenous recombinant tissue plasminogen activator (rtPA) in ischemic stroke patients remains unclear.We aimed to evaluate the effect of AF status no AF, kAF, or AFDAS on functional and survival outcomes in ischemic stroke patients treated with thrombolysis
